UL Solutions director now holds 2,213 RSUs
Director Sally Susman received small dividend-equivalent RSU and DRSU accruals tied to existing UL Solutions equity awards.
Rhea-AI Filing Summary
UL Solutions Inc. (symbol: ULS) is the issuer of record for a Form 4 filing submitted to the SEC. SUSMAN SALLY reported acquisition or exercise transactions in this Form 4 filing.
UL Solutions Inc. (ULS) reported that director Sally Susman received small equity-based awards on September 10, 2026, in the form of 10 Deferred Restricted Stock Units (DRSUs), an additional 5 DRSUs, and 4 Restricted Stock Units (RSUs), each representing one share of Class A Common Stock. The awards reflect accrued dividend equivalent rights on DRSUs and RSUs already held. Following the RSU-related accrual, Susman directly holds 2,213 RSUs, including associated dividend equivalents, which vest by the earlier of May 20, 2027 or the next annual meeting after May 20, 2026. No Rule 10b5-1 trading plan is reported for these transactions.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Deferred Restricted Stock Units F1, F2, F3, F4 | 10 | $0.00 | $0.00 |
| Grant/Award | Deferred Restricted Stock Units F1, F2, F5, F4 | 5 | $0.00 | $0.00 |
| Grant/Award | Restricted Stock Units F1, F6, F7, F8 | 4 | $0.00 | $0.00 |
Footnotes (8)
- F1. Each restricted stock unit ("RSU") and deferred restricted stock unit ("DRSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.
- F2. Represents accrual of dividend equivalent rights on DRSUs held by the Reporting Person.
- F3. The dividend equivalent rights accrued on DRSUs held by the Reporting Person and vest proportionately with the DRSUs to which they relate. The DRSUs vested on May 1, 2025, and will be settled in shares of the Issuer's Class A Common Stock either (i) on a date selected by the Reporting Person pursuant to the Issuer's Non-Employee Director Deferred Compensation Plan (the "Plan"), or (ii) as otherwise provided by the Plan.
- F4. Includes DRSUs and all dividend equivalent rights that have accrued on such DRSUs to date.
- F5. The dividend equivalent rights accrued on DRSUs held by the Reporting Person and vest proportionately with the DRSUs to which they relate. The DRSUs vested on May 20, 2026, and will be settled in shares of the Issuer's Class A Common Stock either (i) on a date selected by the Reporting Person pursuant to the Issuer's Plan, or (ii) as otherwise provided by the Plan.
- F6. Represents accrual of dividend equivalent rights on RSUs held by the Reporting Person.
- F7. The dividend equivalent rights accrued on RSUs held by the Reporting Person and vest proportionately with the RSUs to which they relate. The RSUs vest on the earlier of May 20, 2027, or the date of the annual meeting following the May 20, 2026, grant date.
- F8. Includes RSUs and all dividend equivalent rights that have accrued on such RSUs to date.
Key Figures
Key Terms
Deferred Restricted Stock Units financial
Restricted Stock Units financial
dividend equivalent rights financial
Non-Employee Director Deferred Compensation Plan financial
Class A Common Stock financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What equity awards did UL Solutions Inc. (ULS) director Sally Susman receive on September 10, 2026?
How many UL Solutions (ULS) RSUs does Sally Susman hold after the reported Form 4 transactions?
What do the DRSU grants to the UL Solutions (ULS) director represent?
When will Sally Susman’s UL Solutions (ULS) RSUs from this filing vest?
When did the UL Solutions (ULS) DRSUs tied to these dividend equivalents vest?
Were the UL Solutions (ULS) director’s transactions under a Rule 10b5-1 trading plan?
AI-generated analysis. How Rhea-AI works. Not financial advice.